JCHOR
Journal of Current Hematology & Oncology Research

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge.

ISSN: Active
eISSN: 2980-0854
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Case Report
Secondary cutaneous diffuse large B-Cell lymphomas: bad scenario
Abstract
Primary or secondary cutaneous involvement may occur in common diffuse large B-cell lymphomas. The secondary cutaneous involvement of diffuse large B-cell lymphoma is a condition that develops during the course of the disease and is associated with an aggressive course and shorter survival. The development of secondary cutaneous involvement shortly after the initial diagnosis of the primary disease predicts more aggressive clinical outcomes and is more likely to present with multiple skin lesions.

Keywords : Diffuse large B-Cell lymphomas, cutaneous, primary, secondary

Download Article


1. Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720-1748. doi:10. 1038/s41375-022-01620-2
2. Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019; 134(13):1112-1112. doi:10.1182/blood.2019002852
3. Leary DO, Goyal N, Rubin N, Goyal A. Characterization of primary and secondary cutaneous B-cell lymphomas: a population-based study of 4758 patients. Clin Lymphoma Myeloma Leuk. 2022;22(4):e269-e278. doi:10.1016/j.clml.2021.10.009
4. Pileri A, Sacchelli L, Mussi M, Cedirian S. Secondary lymphomas of the skin. Dermatol Reports. 2023;16(Suppl 2):9743.doi:10.4081/dr.2023.9743
5. Castillo JJ, Winer ES, Olszewski AJ. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the surveillance, epidemiology and end results database. Am J Hematol. 2014;89(3):310-314. doi:10.1002/ajh. 23638
6. Lee W, Won K, Won C, et al. Secondary cutaneous diffuse large B-cell lymphoma has a higher International Prognostic Index score and worse prognosis than diffuse large B-cell lymphoma, leg type. Acta Dermato Venereologica. 2016;96(2):245-250. doi:10.2340/00015555-2139
7. Lee WJ, Won KH, Won CH, et al. Secondary cutaneous lymphoma: comparative clinical features and survival outcome analysis of 106 cases according to lymphoma cell lineage. British J Dermatol. 2015;173(1):134-145. doi:10.1111/bjd.13582
8. Fujita A, Hamada T, Iwatsuki K. Retrospective analysis of 133 patients with cutaneous lymphomas from a single Japanese medical center between 1995 and 2008. J Dermatol. 2011;38(6):524-530. doi:10.1111/j. 1346-8138.2010.01049.x
9. Yasukawa K, Kato N, Kodama K, Hamasaka A, Hata H. The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification. J Cutan Pathol. 2006;33(7):487-491. doi:10.1111/j.1600-0560.2006.00460.x
10. Park JH, Shin HT, Lee DY, et al. World Health Organization-European Organization for research and treatment of cancer classification of cutaneous lymphoma in Korea: a retrospective study at a single tertiary institution. J Am Acad Dermatol. 2012;67(6):1200-1209. doi:10.1016/j.jaad.2012.02.033
11. Kastnerova L, Belousova IE, Hadravsky L, et al. Mummified cells are a common finding in cutaneous hodgkin lymphoma and can be used as a diagnostic clue. Am J Dermatopathol. 2020;42(1):24-28. doi:10.1097/DAD.0000000000001445
12. Cerroni L, Beham-Schmid C, Kerl H. Cutaneous Hodgkin’s disease: an immunohistochemical analysis. J Cutan Pathol. 1995;22(3):229-235. doi: 10.1111/j.1600-0560.1995.tb00743.x
13. Gru AA, Bacchi CE, Pulitzer M, et al. Secondary skin involvement in classic Hodgkin lymphoma: results of an international collaborative cutaneous lymphoma working group study of 25 patients. J Cutan Pathol. 2021;48(11):1367-1378. doi:10.1111/cup.14077
14. Maher NG, Chiang YZ, Badoux X, Vonthethoff LW, Murrell DF. Saggy skin as a presenting sign of angioimmunoblastic T-cell lymphoma. Clin Exp Dermatol. 2016;41(4):386-389. doi:10.1111/ced.12773
15. Wang L, Lee HY, Koh HY, Busmanis I, Lee YS. Cutaneous presentation of angioimmunoblastic T-cell lymphoma: a harbinger of poor prognosis? Skinmed. 2016;14(6):469-471.
16. Pileri A, Cricca M, Gandolfi L, et al. Vemurafenib mucosal side-effect. J Eur Acad Dermatol Venereol. 2016;30(6):1053-1055. doi:10.1111/jdv.13105
17. Placa M La, Bacci F, Gurioli C, et al. Erythematous induration of the chest. JDDG: J Dtsch Dermatol Ges. 2015;13(12):1291-1293. doi:10.1111/ddg.12763
18. Vila-Payeras A, Terrasa-Sagristá F, Nadal-Lladó C, Parera-Amer E. Systemic B-cell lymphoma with skin manifestation clinically resembling granuloma annulare. J Cutan Pathol. 2021;48(5):607-610. doi:10.1111/cup.13779
19. Kim BK, Surti U, Pandya AG, Swerdlow SH. Primary and secondary cutaneous diffuse large B-cell lymphomas. Am J Surg Pathol. 2003;27(3): 356-364. doi:10.1097/00000478-200303000-00009
20. Lee W, Won K, Won C, et al. Secondary cutaneous diffuse large B-cell lymphoma has a higher International Prognostic Index score and worse prognosis than diffuse large B-cell lymphoma, leg type. Acta Dermato Venereologica. 2016;96(2):245-250. doi:10.2340/00015555-2139
Article available in :
Volume 3, Issue 2, 2025
Page : 46-48
https://doi.org/10.51271/JCHOR-0061
Article Information
Received : 07 Şub 2025
Accepted : 23 Şub 2025
Published : 08 May 2025
Corresponding Author :

Sinan Demircioglu: Department of Hematology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkiye

[email protected]
Citation : Demircioğlu S, Çiftçi MG, Baysal S, Merter M, Tekinalp A. Secondary cutaneous diffuse large B-cell lymphomas: bad scenario. J Curr Hematol Oncol Res. 2025;3(2):46-48.

Read: 141
Download : 312
Cited: 0
_Footer